Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Poor you. I will catch you up.
No one will be an exception for that matter.
Good luck with your medical procedures!
Annovis up 160% for 3 days
Hope this kind move happens to Anavex someday soon.
Wow, Anavex has a single digit handicap!
Missling has said in HC Wainright conference back in June 23 that exclusion for Blarcamesine trial was very low at maybe around 10%.
Clearly this is extra impressive for Blarcamesine in regards to their results and low p values etc.
That I agree and they know who they are.
Sigma-1 receptor (S1R) is a unique multi-tasking protein……..
hmmm……..A2-37 might have multi-side effects: Good ones. : )
Very funny analogy. 👍️ There are many staying with him at the Airbnb at the moment. Lol
You probably meant June 28, today. Close.
I'd love to see short interest reduces by a half. What drive them?
I can't read between lines.
Predictions:
1. When the Q2 13 F/D/G forms are filed mid August 2024, there will be about 6-7 million fewer shares held by institutes (or back to 30%)
2. About 7 million shares will trade at or near market close June 30
3. On June 30, at 4:02 pm, the first post will appear being shocked at the volume
4. On June 30, by 4:05 additional posts will express surprise/anger that so many shares were 'bought' without the price jumping up. Manipulation will be mentioned
5. The short interest report +/- July 15, 2024 (first one after June 30) will show short interest down to 10-12 million shares
Powerwalker, For the peace, everyone has freedom of speech and we are on a free message board.
His “Have been here since 2015……..” is just like your “ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!” No personal attack intended.
But can you not feel a 90 min, or even 45 min presentation way heavier than 12 min? : )
I’m excited.
That’s possible too.
1:15 to 2:45 can be just a window for presentations?
I see Biogen also has the same slot, same place in the link below:
https://alz.confex.com/alz/2024/meetingapp.cgi/Paper/90729?fbclid=IwZXh0bgNhZW0CMTEAAR34Y9KVe3VBYyTXGAf0H8h9gFDnnCICs6zRarYy4iK1oQ5TrmOnK089pEI_aem_gWGvtRQIHZp8VFUilpN9WQ&mibextid=Zxz2cZ
Clarification re: "........because of the missed ADL,....." on ST by stjernerogvann
FWIW, ADL played no role in their not having met with FDA yet - that was not said at the annual meeting. What WAS said is that ADL is not something measurable or significant in mild patients, and that the FDA also takes this stance now.
Just can not believe it. How in the world?????? Sigh.....
Dr. M said it didn't really matter in the Q&A at ASM.
You can find one of posts re: recap of ASM.
I remember time when his tone changed and I thought hmmmm..... his words couldn't come from someone who owned shares of the company unless he shorted.
Thank you for sharing it, Hosai.
When asked if European approval would be first and FDA second, he answered not necessarily because though they started with EMA, FDA is much quicker.
It's luxury for us to have two jockeys; FDA approval may come first.
I know I know we need a NDA first.
They have not seen any of the ATTENTION data on the OLE.
Most of us got wrong? We even thought the company probably shared it with EMA, didn't we or just me? What's the point of Open-Label Extension?
.
Were you disappointed? Did you expect something significant? Lol
That's funny. It just amazes me that two opposite statements come from the same mouth. smh
I replayed it and you are correct. Thanks.
Can you guys believe that there are about 120 Alzheimer drugs currently are being developed and 36 of them are in phase 3? Dr. Sabbagh said so in the video linked below at 0:40 mark; talking about A2-73(without calling its name) at 6:00 mark. Hope A2-73 is the 1st one to be approved by EMA and FDA.
https://www.neurologylive.com/view/alzheimer-s-disease-pipeline
Wahahahaha what a joke on a message board. Where did you ‘cut’ that from?
I like to thumbs-up your post but I can’t.
Why doesn’t ihub app have that function?( not a question to you)
Just realized that you don’t see the YouTube link when you use iHub application.
Michal Fox and his wife, a great couple
Still promoting ‘on going’ class action suits. Yup, working hard and you’ll be rewarded.
Unbelievable straight down slide on the day chart. I remember seeing the same pattern about two weeks ago.
Whatever.......
My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate degree in Business Management from Universidad Andina Simon Bolivar, Quito, Ecuador, and the Ph.D. degree in computer applications from the University of Alicante, Spain.
It probably was said before. The graph shows that Anavex's cash reserve jumped x5 in early 2021 which coincide with the historic high of pps at $15, then to $31. Can I safely imagine that Anavex Corp sold bunch of shares in that run? If they did, how savvy Dr. Missling is and I'm happy for that we don't worry about cash for now. Right or wrong?
Yes AVXL 20% up this week!
Thank you for your due diligence as always.
I see that it was filed on Jan 18, 2024.
The author seems to understand A2-73 and the where Anavex Corp stands very well, surprisingly.
10% up at $4.4. They are here.
Will watch the show.
Now 7.7% up at $4.30 per Yahoo finance.
Premarket 6.5% up at $4.25 with volume 3000 shares?
What’s going on? Meme crowd?
Ah.............very refreshing. Thanks!
Thank you and big thanks to MayoMobile!
I can wait one more year; however, I will need a thing or two that I can be distracted with while I'm waiting, like a big jump in pps x2, x3 I hope. : )
Honestly he wouldn’t need any more shares if he can exercise options on 6 million shares. It will be called greed if anyone buy more shares in that situation.
AVXL Calendar- for the rest of year, gathered from Earnings Call Transcript
- 6/18 to 6/19: An educational presentation will be provided at the 2024 IRSF Rett Syndrome Scientific Meeting, taking place this year June 18, 2024 to June 19, 2024
- Mid-2024: as well analysis of RNA sequencing of the trial is underway and interim data is expected by mid-2024.
2H:
- 7/25 to 7/28: the potentially pivotal ANAVEX2-73 Phase 2/3 clinical trial will be presented at the 19th National Fragile X Foundation Conference taking place in July 25, 2024 to July 28, 2024.
- the ATTENTION-AD open-label extension trial is ongoing and we expect to be able to share interim data in the second half of 2024
- PD initiation of an ANAVEX2-73 Phase 2b/3 six-month trial is expected in the second half of 2024.
- EMA Filing: Dr. M "we said we want to submit this year and we are well on track to do that. So we will provide updated timing when we get closer to the filing time. But we have very good on time with that. So stay tuned." ".....There’s also interactions taking place with the EMA to be aligned on the technicalities,...."
Q2 2024 Earnings Call Transcript
For those who can not read on Seeking Alpha website.
https://www.insidermonkey.com/blog/anavex-life-sciences-corp-nasdaqavxl-q2-2024-earnings-call-transcript-1300719/#q-and-a-session